bromocriptine has been researched along with Multiple Endocrine Neoplasia Type 1 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, CX; Qu, HQ; Tian, WJ; Wang, BP; Zhang, J; Zhu, M | 1 |
Guo, R; Lv, J; Pan, M; Pan, Y; Zhang, Y | 1 |
Aizawa, T; Hashizume, K; Katai, M; Oiwa, A; Sakuma, T; Sakurai, A; Sato, Y; Yamashita, K | 1 |
Feldkamp, J; Höppner, W; Neumann, NJ; Schock-Skasa, G; Schuppe, HC | 1 |
4 other study(ies) available for bromocriptine and Multiple Endocrine Neoplasia Type 1
Article | Year |
---|---|
Nonfunctional pancreatic endocrine tumor in the peripancreatic region in a Chinese patient with multiple endocrine neoplasia type 1.
Topics: Adult; Amino Acid Substitution; Bone and Bones; Bromocriptine; Female; Gene Expression; Hormone Antagonists; Humans; Multiple Endocrine Neoplasia Type 1; Mutation, Missense; Pain; Pancreatic Neoplasms; Prolactinoma; Proto-Oncogene Proteins; Tomography, X-Ray Computed | 2018 |
Pituitary Prolactinoma Imaged by 99mTc-Sestamibi SPECT/CT in a Multiple Endocrine Neoplasia Type 1 Patient.
Topics: Adult; Bromocriptine; Female; Hormone Antagonists; Humans; Hypercalcemia; Hyperinsulinism; Hyperparathyroidism, Primary; Hyperprolactinemia; Magnetic Resonance Imaging; Multiple Endocrine Neoplasia Type 1; Parathyroid Glands; Parathyroidectomy; Pituitary Neoplasms; Prolactinoma; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Sestamibi | 2016 |
Pituitary adenomas in adolescent patients with multiple endocrine neoplasia type 1.
Topics: Adolescent; Bromocriptine; Female; Hormone Antagonists; Humans; Male; Multiple Endocrine Neoplasia Type 1; Pedigree; Pituitary Neoplasms; Prolactinoma | 2002 |
Secondary infertility as early symptom in a man with multiple endocrine neoplasia-type 1.
Topics: Adenoma; Adult; Bromocriptine; Erectile Dysfunction; Exons; Hormone Antagonists; Humans; Hyperprolactinemia; Male; Multiple Endocrine Neoplasia Type 1; Mutation; Neoplasm Proteins; Oligospermia; Pituitary Neoplasms; Postoperative Period; Proto-Oncogene Proteins; Sperm Count | 1999 |